Skip to content
GERICLINICS

GeriQBank · Paper III · Q1

Causes and treatment of acute kidney injury in an elderly male

High YieldAsked ×27-mark note
Chapter
Nephrology & Acid–Base
Years asked
Not recorded in the source
Frequency
Set 2× in Paper III (2009–2025)

As set in the university paper

  • Enumerate the causes and outline the treatment of acute kidney injury in an elderly male; and the differentials and investigations in a 65-year-old male with acute kidney injury.

    Paper III · Renal, Fluid & Electrolyte Disorders · asked ×2 · 7-mark note · see in paper list

Answer framework

  1. Definition and the vulnerable old kidney — criteria; tubular frailty; why AKI is commoner; concentrating ability and body water; renal dysautonomia
  2. Causes — prerenal, intrinsic, postrenal; vasculitis and crescentic GN; vascular causes; infection; other causes in a man
  3. The male-specific trap — prostatic obstruction presenting with polyuria
  4. Assessment — limits of urinary indices and creatinine; practical work-up
  5. Treatment — relieve prerenal and postrenal causes; correct complications; specific therapy; dialysis; prognosis; prevention
  6. Recent updates — KDIGO 2026 draft (AKI–AKD–CKD continuum, biomarker staging, cystatin C), contrast-associated AKI, sick-day rules, balanced crystalloids

An exam answer plan drawn from the detailed answer below. Use it to attempt the question first.

Detailed answer

Pro · free in beta
Attempt it firstOutline your answer as a 7-mark note before revealing it — definition, causes, evaluation, management and the geriatric angle.Reveal answer

Short revision answer

  • AKI is an abrupt, potentially reversible fall in GFR: a creatinine rise of ≥0.3 mg/dL in 48 hours or to ≥1.5 times baseline within 7 days, or urine output <0.5 mL/kg/hour for 6 hours. If the kidney has not recovered by about 3 months, it is left as CKD.
  • The old kidney is vulnerable: tubular frailty (ATN develops easily and recovers slowly), concentrating ability falling about 30 mOsmol/kg per decade, a higher thirst threshold, body water of about 54% (vs 65% in the young) and loss of autonomic vascular reflexes. The cause is usually multifactorial.
  • Prerenal: dehydration (the commonest cause), haemorrhage, shock. Intrinsic: ATN (the commonest intrinsic lesion), nephrotoxins (aminoglycosides, contrast), glomerulonephritis, interstitial nephritis. Postrenal: stones, tumour, stricture and — in a man — the prostate.
  • Renal vasculitis is probably the commonest primary cause of renal failure in older adults, and crescentic GN peaks at 60–79 years. Also consider renovascular disease (an ACE inhibitor in bilateral stenosis), atheroembolism, pyelonephritis, myeloma, tumour lysis and rhabdomyolysis after a long lie.
  • Prostatic obstruction causes gradual loss of function with polyuria rather than oliguria, so it is recognised late and may not fully recover.
  • In older people, urinary sodium, FENa and FEUrea can be high even in prerenal AKI, and creatinine underestimates damage (about 50% of function is lost before it rises). Work-up: volume status and postural BP, drug chart, bladder scan and ultrasound, urine microscopy, potassium, bicarbonate, CK, protein electrophoresis, and ANCA/anti-GBM if the picture is rapidly progressive.
  • Treatment: relieve obstruction (catheter or nephrostomy), restore volume, treat sepsis and stop nephrotoxins (DAMN — diuretics, ACE inhibitors/ARBs, metformin, NSAIDs). Correct hyperkalaemia (to which older people are predisposed), acidosis and fluid overload, and dose every drug to GFR.
  • Specific therapy: withdraw the culprit drug (± steroids) in interstitial nephritis; steroids with cyclophosphamide for vasculitis. Dialyse when needed, watching for hypotension, bleeding and disequilibrium. Age itself is not an important determinant of survival.
  • Prevention: maintain extracellular volume, dose drugs to GFR, stop nephrotoxins before surgery and monitor aminoglycoside levels.
  • KDIGO 2026 draft: an AKI → AKD → CKD continuum (AKD lasting up to 3 months); staging by creatinine, urine output and damage biomarkers; cystatin C when muscle mass is low; electronic alerts and structured follow-up. Also: "contrast-associated AKI", sick-day rules, and balanced crystalloids over saline. Dopamine, mannitol and routine loop diuretics do not help.

Condensed by GeriClinics from the detailed answer below, with no new facts added.

15 MARKS

Causes and treatment of acute kidney injury in an elderly male High-Yield Points A. Definition and Why the Old Kidney Is Vulnerable

1.

AKI is an abrupt, potentially reversible fall in glomerular filtration over hours to days, with retention of nitrogenous waste. Standard criteria: rise in serum creatinine by ≥0.3 mg/dL in 48 hours, or ≥1.5 times baseline within 7 days, or urine output <0.5 mL/kg/hour for 6 hours.

2.

Tubular frailty is the key ageing change — tubular cells in the elderly injure easily, progress readily to acute tubular necrosis (ATN), and recover slowly. If the kidney has not recovered by about 3 months, it is left as chronic kidney disease.

3.

AKI is commoner in older adults because of frequent systemic illness (diabetes, myeloma), polypharmacy, and the renal ageing process itself. The cause is usually multifactorial, not single.

4.

Ageing reduces urine concentrating power (falls about 30 mOsmol/kg per decade), raises the thirst threshold, and lowers total body water to about 54% of body weight (65% in the young) — so dehydration develops very easily.

5.

Renal dysautonomia and loss of the autonomic vascular reflex mean the aged kidney is damaged during both hypotensive and hypertensive episodes.

B. Causes — Classification (write this as a table in the exam)

6.

Prerenal: dehydration is the main cause; also haemorrhage and shock (cardiogenic and septic).

7.

Renal (intrinsic): ATN from persisting prerenal causes or from nephrotoxins (aminoglycosides, contrast); rapidly progressive damage from primary or secondary glomerular disease; acute interstitial nephritis.

8.

Postrenal (obstructive): stones, tumour, stricture and — the key one in a male — prostatic hypertrophy.

9.

Renal vasculitis becomes commoner with age and is probably the commonest primary cause of renal failure in older adults; granulomatosis with polyangiitis and microscopic polyangiitis both rise with age. Crescentic glomerulonephritis peaks at 60–79 years and typically presents as rapidly evolving AKI.

10.

Vascular causes: renovascular atherosclerosis and ischaemic nephropathy; reversible renal failure after an ACE inhibitor in bilateral renal artery stenosis; intrarenal atheroembolism, from which the kidney rarely recovers.

11.

Urinary tract infection / pyelonephritis is the commonest infection in the elderly, and its pathogenesis is strongly linked to obstructive uropathy; risk is raised further by urethral and vaginal atrophy, bed-rest puddling and catheterisation.

12.

Add in a man specifically: myeloma kidney, tumour lysis syndrome, rhabdomyolysis after a long lie, and heat-related illness.

C. The Male-Specific Trap — Obstructive Uropathy

13.

Prostatic hypertrophy occurs to some degree in nearly all ageing men; in a proportion it causes slow outflow obstruction with gradual loss of kidney function.

14.

It is often recognised too late, because the patient becomes polyuric rather than oliguric. By the time obstruction is diagnosed, damage may be irreversible, and relief of obstruction restores function only partially.

D. Assessment

15.

Urinary indices behave differently in the elderly: a high urinary sodium, fractional excretion of sodium or fractional excretion of urea does not exclude prerenal AKI, because the aged kidney normally loses sodium and urea.

16.

Serum creatinine underestimates the damage. Renal function falls by about 50% before creatinine rises, and reduced muscle mass plus net tubular creatinine reabsorption in the elderly delay the rise further.

17.

Practical work-up: volume status and postural blood pressure, complete drug chart, bladder scan and ultrasound KUB for obstruction, urinalysis with microscopy, serum potassium and bicarbonate, creatine kinase, serum and urine protein electrophoresis, and ANCA / anti-GBM if a rapidly progressive picture is suspected.

E. Treatment

18.

Prerenal and postrenal causes matter most — their early identification and treatment may prevent the development of, or reverse, established AKI. Catheterise or place a nephrostomy promptly; restore extracellular volume; treat sepsis; stop nephrotoxic drugs.

19.

Correct complications: hyperkalaemia (the elderly are already predisposed because of low aldosterone and reduced tubular response, and worsen further on NSAIDs, ACE inhibitors, beta blockers and potassium-sparing diuretics), metabolic acidosis and fluid overload. Adjust every drug dose to the measured GFR.

20.

Specific therapy: withdraw the culprit drug in interstitial nephritis, with steroids if needed; steroids with cyclophosphamide for vasculitis and crescentic glomerulonephritis, used as in younger adults but with closer attention to side effects.

21.

Dialysis: temporary or permanent support may be needed. AKI is treated much the same in old and young, but older patients are more vulnerable to dialysis-related complications — haemodynamic instability, bleeding and disequilibrium syndrome.

22.

Prognosis: age by itself is not an important determinant of survival in AKI. Failure to recover by about 3 months leaves chronic kidney disease.

23.

Prevention is paramount: maintain an adequate extracellular volume and tailor drug dosing to GFR. Perioperatively, estimate GFR (CKD-EPI is regarded as most accurate, Cockcroft–Gault as most sensitive), stop nephrotoxic drugs before surgery, review diuretics against the planned procedure, titrate aminoglycoside dosing intervals to plasma levels, and optimise renal perfusion with haemodynamic monitoring.

Latest Updates (2023–Present)

KDIGO 2026 AKI/AKD Guideline (public review draft, March 2026) — the first major revision since 2012, considering evidence to June 2025. It replaces "AKI alone" with an AKI → AKD → CKD continuum. Acute kidney disease (AKD) covers abnormality persisting up to 3 months, and AKD following AKI is separated from AKD without AKI. Three-axis staging is proposed: C (serum creatinine), U (urine output) and B (damage biomarker, reported as B− or B+). This lets a patient be "biomarker-positive" before creatinine moves.

Cystatin C is accepted as an alternative functional criterion (≥1.5× baseline within 7 days) when creatinine is unreliable — directly relevant to sarcopenic older adults. Kinetic eGFR is suggested in hospitalised patients when a GFR estimate is needed under non-steady-state conditions.

New content on validated risk-prediction models, electronic AKI alerts, urine microscopy as part of evaluation, drug and nephrotoxin stewardship, and structured post-AKI follow-up to reduce later CKD and cardiovascular events.

Terminology has shifted from "contrast-induced nephropathy" to contrast-associated AKI (CA-AKI), reflecting multifactorial causation rather than pure contrast toxicity; main risks are eGFR <60 mL/min/1.73 m², diabetes, volume depletion, high contrast volume and the intra-arterial route.

Sick-day medication guidance (international modified-Delphi consensus, AJKD) is now standard for community-acquired AKI prevention: temporarily withhold volume-depleting and nephrotoxic drugs during acute dehydrating illness, and treat restarting them as being as important as stopping them.

Balanced crystalloids are generally preferred to 0.9% saline for large-volume resuscitation, avoiding hyperchloraemic acidosis; low-dose dopamine, mannitol and routine loop diuretics remain of no benefit for AKI prevention or treatment.

Current Practice Update

Issue Textbook position Current evidence (2023–2026)

Framework AKI described as a discrete event, with CKD if no Formal AKI–AKD–CKD continuum, with AKD as a recovery at ~3 months named intermediate stage requiring its own follow-up Diagnosis Serum creatinine and urinary indices, with the Creatinine + urine output + damage biomarkers; caveat that they mislead in the elderly cystatin C when muscle mass is low; kinetic eGFR in unstable patients Detection Clinical suspicion by the treating team Electronic AKI alerts and validated risk-prediction models built into hospital systems Contrast Contrast listed as a nephrotoxin Contrast-associated AKI; risk-stratified, lower contrast volumes; prophylaxis mainly isotonic fluid, not N-acetylcysteine Prevention Maintain volume, dose drugs to GFR Same core, plus formal nephrotoxin stewardship, pharmacist-led review and sick-day rules After recovery Recovery or progression to CKD Structured post-AKI follow-up is now a guideline recommendation, since AKI survivors carry excess CKD, cardiovascular and mortality risk Exam One-Liners Commonest cause of AKI in the elderly: dehydration (prerenal).

Commonest intrinsic lesion: acute tubular necrosis.

Commonest primary cause of renal failure in older adults: renal vasculitis.

Crescentic glomerulonephritis peaks at 60–79 years and presents as rapidly evolving AKI. Obstruction in an elderly male presents with polyuria, not oliguria — the single most examined trap. A raised FENa does not exclude prerenal AKI in the elderly.

Age per se is not an important determinant of survival in AKI.

Older patients are more prone to intradialytic hypotension, bleeding and disequilibrium syndrome. Non-recovery at 3 months = chronic kidney disease.

Extra Recall Points — Recurring Topic

Mnemonics

Causes — "3 P's": Pre-renal (dehydration), Parenchymal (ATN, AIN, vasculitis), Prostate (obstruction). In an elderly male, always finish with the prostate.

Reversible drivers — "DAMN": Diuretics, ACE inhibitors/ARBs, Metformin, NSAIDs — the four to stop at the bedside on day one.

Bedside actions — "STOP-AKI": Sepsis treated, Toxins stopped, Optimise perfusion and volume, Prevent obstruction (catheterise/scan).

Numerical Anchors

Creatinine rise ≥0.3 mg/dL in 48 h or ≥1.5× baseline in 7 days; urine output <0.5 mL/kg/h × 6 h. Concentrating capacity falls ~30 mOsmol/kg per decade; minimum urine osmolality 92 vs 52 mOsmol/kg (old vs young); maximum free-water clearance 5.9 vs 16.2 mL/min.

Total body water 54% vs 65% of body weight.

Renal function must fall ~50% before creatinine rises.

Non-recovery window: 3 months. Dialysis in CKD when GFR <10 mL/min.

Examiner Traps

1.

Writing "oliguria" for obstructive uropathy in a man — it is classically polyuric.

2.

Using FENa >1% to call it ATN in an 80-year-old — the aged kidney loses sodium anyway.

3.

Saying "old age makes AKI fatal" — age itself is not an important survival determinant.

4.

Forgetting that the cause is usually multifactorial; listing only one.

5.

Quoting a normal creatinine as reassurance in a sarcopenic patient.

6.

Omitting renal vasculitis, which is the commonest primary cause of renal failure in this age group.

15-Second Answer Skeleton

Define AKI → ageing kidney is primed (tubular frailty, dehydration-prone, dysautonomia) → causes in three columns: prerenal / renal / postrenal → stress dehydration and prostate → assessment pitfalls (creatinine and FENa unreliable) → treatment: volume, sepsis, stop nephrotoxins, relieve obstruction, correct potassium and acidosis, dose to GFR, dialysis if needed → prognosis and prevention → KDIGO 2026 AKI/AKD continuum with biomarkers and cystatin C.

How was your recall?

Rating marks the question complete. “Need another pass” also adds it to your bookmarks.

References

Spotted an error or something out of date?Report a problem with this page